The clinical, preclinical, and basic research of A-CURE focuses primarily on the use of the Impella® heart pump, a transvalvular microaxial flow pump, as the means to unload the heart.
William O’Neill, MD discusses best practice protocols for AMI cardiogenic shock demonstrated in data from the Impella Quality (IQ) Database as well as the cVAD Study®.
This study shows that presence of CTO in patients with coronary artery disease (CAD) with ischemic heart failure results in adverse long-term prognosis.
Rahul Sharma, MD, discusses femoral closure including the importance of femoral angiograms, manual pressure technique for hemostasis, and post-cath orders.
